期刊
BLOOD REVIEWS
卷 31, 期 2, 页码 11-16出版社
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.blre.2016.09.001
关键词
Ph-like ALL; BCR-ABL-like ALL; Kinase-driven ALL; Tyrosine kinase inhibitors; JAK inhibitors
类别
资金
- Israel Science Foundation
- Israel Cancer Research Foundation
- European Union ERA-NET TRANSALL
- Waxman Cancer Research Foundation
Recent comprehensive genetic studies revealed numerous genetic aberrations underlying a group of high-risk leukemias that share a specific activated kinase gene expression pattern. These ALLs were first recognized by the expression profile similar to that of Philadelphia chromosome-positive ALL and currently can be sub-classified by the main aberrantly activated kinase in the leukemic cells. We herein review the biological mechanisms and diagnostic and clinical challenges presented by these leukemias. (C) 2016 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据